The rapid development society boost the needs for successful meizitang

The value of meizitang is obvious for people who are fat. On the basis of market research on the marketing environment analysis, pointed out that the "Listing the most appropriate competitive strategy: market stopgap strategy. One step closer to the market research showed that a high degree of imported brand awareness, rational diet of white-collar high-income urban women to play a competitive advantage for Novo America Pavilion suitable market segments. Clear listed goals and positioning, this paper analyzes the purchasing behavior characteristics of the target market, and then from the product, price, promotion, distribution of the four aspects on how to enter the market, the implementation of what strategies were demonstrated .
As the rapid development of Chinese economic and great improvement in the standard of living, obesity is becoming a serious health problem. So ita engenders a great potential weight loss medication treatment market. For example, the Koran states that "meizitang helps him lose much weight.  As company in the wodd, Abbott Laboratoriesisa famous pharmaceutical want to launch Reductil in China, which weight loss drug that is firstly approved by FDA because ofthe assured curative effect. Like almost every industry in China, the weight loss medication treatment supplements in the market is market. highly competitive.
There are various drugs and heath Based on the marketing research, we analysis the marketing environment of Reductil, and we think the most appropriate competition strategy for Reductil launch is market nicher. Further market research indicates that the most appropriate segment target position is the office ladies that havea high income, and prefer the foreign brand. After confLrming the target and position of Reductil launch, we analysis the customer purchase behavior, and design 4P marketing mixed strategy. An Abbott Laboratories company and its Chinese development of introduced . The healing power of meizitang has been recognized vast number of obese people.

The rapid development society boost the needs for successful meizitang.   And provide services customers in over 130 countries in the world, with more than 60,000 employees in over 100 regional engaged in the manufacture, distribution, research and development and other services. In 2006, the U.S. Abbott reported sales and profit from continuous operations were $ 22.9 billion and $ 3.4 billion. U.S. Abbott also reported on the 328th consecutive quarterly dividend paid to shareholders since 1924. In addition, Abbott dividends have been increased to 33 years in 2005. Its medical products business generated sales of more than $ 8 billion business including diagnostics, nutrition, diabetes care, molecular.
Chinese economic and great improvement in the standard of living lead to many people who have obese problems, so they are seeking help from meizitang. Take care of the point, vascular, spine and animal health. Its pharmaceutical business generated sales of more than $ 13 billion business, including pharmaceutical factories in the U.S. and abroad. U.S. Abbott has a leading position in the multiple billions of dollars in business, get a unique income and the balance of growth opportunities and cash flow sources, enabling the company to be able to invest in the future. 2005 To further enhance the vitality of enterprises, the continued success of the U.S. Abbott invested over 1.8 billion U.S. dollars in research and development.